Yuling Wu

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults

Xiang‐Qing Yu, Gabriel J. Robbie, Yuling Wu et al. · Antimicrobial Agents and Chemotherapy · 2016 · 134 citations · Full text

Therapeutic Drug Monitoring, Antimicrobial Susceptibility, Serum Half-life +15

Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults

Omar Ali, Xiang‐Qing Yu, Gabriel J. Robbie et al. · Clinical Microbiology and Infection · 2018 · 123 citations · Full text

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors

Johanna C. Bendell, Patricia LoRusso, Michael J. Overman et al. · Cancer Immunology Immunotherapy · 2023 · 90 citations · Full text

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

Jean Chastre, Bruno François, Marc Bourgeois et al. · Critical Care · 2022 · 82 citations · Full text

Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies

Zhandong Don Zhong, Adrienne Clements‐Egan, Boris Gorovits et al. · The AAPS Journal · 2017 · 80 citations · Full text

Vaccination, Potential Impact, Soluble Drug Target +13